Literature DB >> 32615049

The emerging role and significance of circular RNAs in viral infections and antiviral immune responses: possible implication as theranostic agents.

Faryal Mehwish Awan1, Burton B Yang2,3,4, Anam Naz1, Aneeqa Hanif1, Aqsa Ikram5, Ayesha Obaid5, Arif Malik1, Hussnain Ahmed Janjua5, Amjad Ali5, Sumaira Sharif1.   

Abstract

Circular RNAs (circRNAs) are ubiquitously expressed, covalently closed rings, produced by pre-mRNA splicing in a reversed order during post-transcriptional processing. Circularity endows 3'-5'-linked circRNAs with stability and resistance to exonucleolytic degradation which raises the question whether circRNAs may be relevant as potential therapeutic targets or agents. High stability in biological systems is the most remarkable property and a major criterion for why circRNAs could be exploited for a range of RNA-centred medical applications. Even though various biological roles and regulatory functions of circRNAs have been reported, their in-depth study is challenging because of their circular structure and sequence-overlap with linear mRNA counterparts. Moreover, little is known about their role in viral infections and in antiviral immune responses. We believe that an in-depth and detailed understanding of circRNA mediated viral protein regulations will increase our knowledge of the biology of these novel molecules. In this review, we aimed to provide a comprehensive basis and overview on the biogenesis, significance and regulatory roles of circRNAs in the context of antiviral immune responses and viral infections including hepatitis C virus infection, hepatitis B virus infection, hepatitis delta virus infection, influenza A virus infection, Epstein-Barr virus infection, kaposi's sarcoma herpesvirus infection, human cytomegalovirus infection, herpes simplex virus infection, human immunodeficiency virus infection, porcine epidemic diarrhoea virus infection, ORF virus infection, avian leukosis virus infection, simian vacuolating virus 40 infection, transmissible gastroenteritis coronavirus infection, and bovine viral diarrhoea virus infection. We have also discussed the critical regulatory role of circRNAs in provoking antiviral immunity, providing evidence for implications as therapeutic agents and as diagnostic markers.

Entities:  

Keywords:  Non-coding RNAs; antiviral immune responses; circular RNAs; rna sequencing; viral infections

Mesh:

Substances:

Year:  2020        PMID: 32615049      PMCID: PMC7833768          DOI: 10.1080/15476286.2020.1790198

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  116 in total

1.  Differential expression profile of hepatic circular RNAs in chronic hepatitis B.

Authors:  T-C Zhou; X Li; L-J Chen; J-H Fan; X Lai; Y Tang; L Zhang; J Wei
Journal:  J Viral Hepat       Date:  2018-07-11       Impact factor: 3.728

2.  A small circular TAR RNA decoy specifically inhibits Tat-activated HIV-1 transcription.

Authors:  P R Bohjanen; R A Colvin; M Puttaraju; M D Been; M A Garcia-Blanco
Journal:  Nucleic Acids Res       Date:  1996-10-01       Impact factor: 16.971

Review 3.  Herpesviruses and Their Host Cells: A Successful Liaison.

Authors:  Barbara Adler; Christine Sattler; Heiko Adler
Journal:  Trends Microbiol       Date:  2016-12-09       Impact factor: 17.079

Review 4.  Persistent bovine viral diarrhea virus (BVDV) infection in cattle herds.

Authors:  A Khodakaram-Tafti; G H Farjanikish
Journal:  Iran J Vet Res       Date:  2017       Impact factor: 1.376

5.  Comprehensive analysis of circRNAs expression profiles in different periods of MDBK cells infected with bovine viral diarrhea virus.

Authors:  Cunyuan Li; Xiaoyue Li; Xiaoxu Hou; Wei Ni; Mengdan Zhang; Huixiang Li; Yueren Xu; Wureli Hazi; Qiman Ma; Yunfeng Zhang; Dawei Wang; Shengwei Hu
Journal:  Res Vet Sci       Date:  2019-05-06       Impact factor: 2.534

Review 6.  Emergent human pathogen simian virus 40 and its role in cancer.

Authors:  Regis A Vilchez; Janet S Butel
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

Review 7.  Current Scenario of HIV/AIDS, Treatment Options, and Major Challenges with Compliance to Antiretroviral Therapy.

Authors:  Adnan Bashir Bhatti; Muhammad Usman; Venkataramana Kandi
Journal:  Cureus       Date:  2016-03-01

Review 8.  Immunity to Avian Leukosis Virus: Where Are We Now and What Should We Do?

Authors:  Min Feng; Xiquan Zhang
Journal:  Front Immunol       Date:  2016-12-21       Impact factor: 7.561

Review 9.  Herpesviruses: Harmonious Pathogens but Relevant Cofactors in Other Diseases?

Authors:  Sharvan Sehrawat; Dhaneshwar Kumar; Barry T Rouse
Journal:  Front Cell Infect Microbiol       Date:  2018-05-25       Impact factor: 5.293

10.  First retrospective studies with etiological confirmation of porcine transmissible gastroenteritis virus infection in Argentina.

Authors:  Pablo Enrique Piñeyro; Maria Inez Lozada; Laura Valeria Alarcón; Ramon Sanguinetti; Javier Alejandro Cappuccio; Estefanía Marisol Pérez; Fabio Vannucci; Alberto Armocida; Darin Michael Madson; Carlos Juan Perfumo; Maria Alejandra Quiroga
Journal:  BMC Vet Res       Date:  2018-09-24       Impact factor: 2.741

View more
  21 in total

Review 1.  Minor and major circRNAs in virus and host genomes.

Authors:  Zhihao Lou; Rui Zhou; Yinghua Su; Chun Liu; Wenting Ruan; Che Ok Jeon; Xiao Han; Chun Lin; Baolei Jia
Journal:  J Microbiol       Date:  2021-02-23       Impact factor: 3.422

2.  Circular RNA circPIKfyve acts as a sponge of miR-21-3p to enhance antiviral immunity through regulating MAVS in teleost fish.

Authors:  Hui Su; Qing Chu; Weiwei Zheng; Renjie Chang; Wenya Gao; Lei Zhang; Tianjun Xu
Journal:  J Virol       Date:  2021-02-03       Impact factor: 5.103

3.  Exosomal Circular RNA hsa_circ_0046060 of Umbilical Cord Mesenchymal Stromal Cell Ameliorates Glucose Metabolism and Insulin Resistance in Gestational Diabetes Mellitus via the miR-338-3p/G6PC2 Axis.

Authors:  Minkai Cao; Chaozhi Bu; Jingjing Zhang; Yongwei Ren; Guanlun Zhou; Chao Chen; Guorong Han; Shi-Wen Jiang; Juan Wen
Journal:  Int J Endocrinol       Date:  2022-06-11       Impact factor: 2.803

4.  The role of estrogen in circular RNA and metabonomics in a Neisseria gonorrhoeae infection model.

Authors:  Guiyue Cai; Jin Long; Ruitao Zou; Huizhi Yang; Jiahao Xie; Chunchan Zheng; Xiaoxuan Chen; Shuang Liu; Rongyi Chen
Journal:  Ann Transl Med       Date:  2022-09

Review 5.  Targeting circular RNAs as a therapeutic approach: current strategies and challenges.

Authors:  Alina T He; Jinglei Liu; Feiya Li; Burton B Yang
Journal:  Signal Transduct Target Ther       Date:  2021-05-21

6.  circEHBP1 promotes lymphangiogenesis and lymphatic metastasis of bladder cancer via miR-130a-3p/TGFβR1/VEGF-D signaling.

Authors:  Jiang Zhu; Yuming Luo; Yue Zhao; Yao Kong; Hanhao Zheng; Yuting Li; Bowen Gao; Le Ai; Hao Huang; Jian Huang; Zhihua Li; Changhao Chen
Journal:  Mol Ther       Date:  2021-02-03       Impact factor: 11.454

Review 7.  The role of circular RNAs in viral infection and related diseases.

Authors:  He Xie; Honggang Sun; Rongrong Mu; Shilin Li; Yujia Li; Chunhui Yang; Min Xu; Xiaoqiong Duan; Limin Chen
Journal:  Virus Res       Date:  2020-10-22       Impact factor: 3.303

8.  Role of circRNAs in viral infection and their significance for diagnosis and treatment (Review).

Authors:  Yuyao Mo; Yuze Liu; Anni Lu; Hanyi Zhang; Lijun Tang
Journal:  Int J Mol Med       Date:  2021-03-31       Impact factor: 4.101

9.  Circular RNA circDtx1 regulates IRF3-mediated antiviral immune responses through suppression of miR-15a-5p-dependent TRIF downregulation in teleost fish.

Authors:  Weiwei Zheng; Qing Chu; Liyuan Yang; Lingping Sun; Tianjun Xu
Journal:  PLoS Pathog       Date:  2021-03-18       Impact factor: 6.823

10.  A circular RNA derived from PLXNB2 as a valuable predictor of the prognosis of patients with acute myeloid leukaemia.

Authors:  Leilei Lin; Yu Wang; Sicheng Bian; Lili Sun; Zhibo Guo; Desheng Kong; Linlin Zhao; Dan Guo; Qi Li; Min Wu; Yuhuang Wang; Yuying Wang; Yinghua Li
Journal:  J Transl Med       Date:  2021-03-23       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.